The 'Break Even' Cost Of Kidney Transplants Is Shrinking

May 20, 1999

The cost of a kidney transplant has dropped so significantly that University of Maryland School of Medicine researchers say it is cheaper to have a transplant than to stay on dialysis for more than two and a half years, even among the sickest patients.

"We found that the break even point was 2.7 years for all of the cases we analyzed. And, for 30 percent of our patients who did not need to be re-admitted to the hospital during the year after their transplant, the break even point was only 1.7 years," says Eugene J. Schweitzer, M.D., a transplant surgeon at the University of Maryland Medical Center and associate professor of surgery at the University of Maryland School of Medicine.

Dr. Schweitzer will present findings at the American Society of Transplant Surgeons meeting in Chicago on May 20 which show that a kidney transplant is much more cost effective than dialysis even for the highest risk patients-those with heart disease, diabetes or older age. That analysis was done on 227 patients who received kidneys from living donors from March 1996 to December 1998.

A separate, detailed analysis by University of Maryland researchers of 184 transplant patients came up with the break even point of 2.7 years compared to dialysis. That study was published in the journal, Transplantation, in December 1998.

"Our studies show that not only does a kidney transplant improve the quality of life for patients, it also saves money in the long run," says Stephen T. Bartlett, M.D., head of the division of Transplant Surgery at the University of Maryland Medical Center and professor of surgery and medicine at the University of Maryland School of Medicine.

The analysis found that after 2.7 years, the medical system saves about $27,000 per year for each patient who has a transplant instead of remaining on kidney dialysis. By comparison, in 1989, studies elsewhere had shown the break even point to be 3.6 years. About 220,000 people are on kidney dialysis in the U.S.

The major cost saving comes from shortening the length of hospital stay from an average of 10 to 7 days after the transplant, and eliminating the use of expensive anti-rejection drugs that were given intravenously in the hospital following the operation. Better oral anti-rejection medications are now available which patients can take at home. In addition, the increased use of living donor kidneys can reduce costs, since those kidneys tend to function better right after the transplant than those from cadaver donors.

"The cost of kidney dialysis averages about $44,000 per year per patient, using 1993 figures. The average cost for the transplant patients in our study, including the transplant surgery and medical care for the first year following surgery was $89,939. After the first year, costs for the transplant patients averaged $16,043; mostly for medications to prevent rejection.

"We have a focused, comprehensive program for our transplant patients and their families that includes a lot of education and support both before and after the transplant, which has enabled us to get patients out of the hospital sooner," says Dr. Bartlett. "In fact, one-third of our patients are now able to go home within three days of their transplant, without an increased risk of re-admission," he adds.

University of Maryland Medical Center

Related Kidney Transplant Articles from Brightsurf:

The effects of social determinants of health on kidney transplant candidates
Social determinants of health are associated with patient-reported outcomes in adults who are eligible to undergo kidney transplantation evaluations.

Tailored education system to benefit kidney transplant patients
Researchers find their computer-tailored education system, 'Your Path to Transplant' increases knowledge and readiness to pursue kidney transplant.

Kidney transplant, the cost of accounting for patients' preferences
Taking into account patients' preferences can help speed up the organ allocation process and improve the life quality of the recipients, as shown by a joint study conducted by Ca' Foscari University and the University of Padua

New hope for kidney revival for transplant
Cell therapy delivered directly to the kidney can revive a 'marginal' organ, improving function and could offer new hope for providing more kidneys for transplant.

Are kidney transplant patients at higher risk? The European experience
The risk of death is relatively high in kidney transplant patients admitted to hospital with COVID-19.

The economic burden of kidney transplant failure in the United States
A recent analysis published in the American Journal of Transplantation estimates that for the average US patient who has undergone kidney transplantation, failure of the transplanted organ (graft failure) will impose additional medical costs of $78,079 and a loss of 1.66 quality-adjusted life years.

Mixed chimerism improves long-term kidney transplant outlook
Mixed chimerism - the continued mixing of donor and recipient blood cells following a transplant of blood progenitor cells - could improve outcomes for kidney transplant recipients, according to a new clinical study in about 50 patients.

Kidney paired donation is an excellent option for transplant candidates
An analysis compared transplant recipients who received kidneys through national kidney paired donation and those who received kidneys from other living donors (such as relatives, friends or other paired exchange mechanisms).

Mediterranean diet may help preserve the kidney health of transplant recipients
In a study of kidney transplant recipients, those with higher adherence to the Mediterranean diet were less likely to experience kidney function loss.

New blood test can detect rejection by antibodies after kidney transplant
A group of European scientists led by KU Leuven has found a biomarker that can identify patients with symptoms of kidney rejection symptoms after a transplant as a result of antibodies.

Read More: Kidney Transplant News and Kidney Transplant Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to